LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
9/30/2025 | 6/30/2025 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | $61,234 | – | $61,245 |
| - Cash | $269,744 | $14,225 | – | $0 |
| + Debt | $2,936 | $3,761 | – | $0 |
| Enterprise Value | – | $50,770 | – | $61,245 |
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$81 | – | -$5 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,475 | – | -$14,176 | -$27,051 |
| % Margin | – | – | – | – |
| Net Income | -$3,556 | – | -$14,181 | -$27,696 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | – | -0.63 | -7.82 |
| % Growth | – | – | 91.9% | – |
| Operating Cash Flow | – | – | -$22,037 | -$15,777 |
| Capital Expenditures | – | – | -$443 | -$41 |
| Free Cash Flow | – | – | -$22,480 | -$15,818 |